Balanced news tone
News Sentiment
NVO sentiment intelligence
Novo Nordisk A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
31 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-1.6% over one week, -3.9% over four weeks, trend inactive, and below fair value.
Novo Nordisk A/S Stock (NVO) Moved Up by 6.81% on Jun 22: What Investors Need To Know
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-1.6%
Price digesting
Trend fit
Trend inactive
-3.9% over four weeks
Fair value
-46.9%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
24
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingKey
Direct company coverage
Novo Nordisk A/S Stock (NVO) Moved Up by 6.81% on Jun 22: What Investors Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 16:15
- Source
- TradingKey
Blockonomi
Direct company coverage
Novo Nordisk (NVO) Stock Surges 6.55% on Oral Wegovy UK Approval
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 22 Jun 2026 15:49
- Source
- Blockonomi
Insider Monkey
Direct company coverage
Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 13:13
- Source
- Insider Monkey
Moomoo
Direct company coverage
BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Hold Rating, Maintains Target Price $45
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 22 Jun 2026 12:40
- Source
- Moomoo
Quiver Quantitative
Direct company coverage
Novo Nordisk Stock (NVO) Opinions on Analyst Upgrade and Valuation Reset
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 21 Jun 2026 17:33
- Source
- Quiver Quantitative
Stocktwits
Direct company coverage
Novo Nordisk Stock Up Over 2% Premarket Today — Thanks To OpenAI Tie-Up
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 05:21
- Source
- Stocktwits
simplywall.st
Direct company coverage
Novo Nordisk (NYSE:NVO) Faces Cyber Breach While Pushing Oral Wegovy Into China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 20:38
- Source
- simplywall.st
simplywall.st
Direct company coverage
Novo Nordisk (NVO) Stock Could Be 54.5% Undervalued After Its 90 Day Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 15:29
- Source
- simplywall.st
TIKR.com
Direct company coverage
Down 42% in the Last 12 Months, Can Novo Nordisk Stock Bounce Back in 2026?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 10:20
- Source
- TIKR.com
Mshale
Direct company coverage
Novo Nordisk Stock (NVO) REALITY SHIFT: Weight-Loss Pill Changes Game Nancy Grace (oDsI85S136)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 02:15
- Source
- Mshale
TradingView
Direct company coverage
Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 14:40
- Source
- TradingView
Seeking Alpha
Direct company coverage
Novo Nordisk: The Danish Empire Strikes Back (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:34
- Source
- Seeking Alpha
Stock Titan
Direct company coverage
Novo Nordisk (NVO) repurchases 19.9M B shares under 2026 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 11:42
- Source
- Stock Titan
TradingView
Direct company coverage
Novo Nordisk Stock Up as UK Wegovy Pill Nod Eclipses Security Breach
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Novo Nordisk (NYSE:NVO) Stock Valuation Gap Questioned After Recent Share Price Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Novo Nordisk (NYSE: NVO) details progress on DKK 15B share repurchase plan
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 08 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
The Motley Fool
Direct company coverage
Here's What I Think Is Really Going on With Novo Nordisk Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- The Motley Fool
Stock Titan
Direct company coverage
Novo Nordisk (NVO) details DKK 4.7B progress on 12-month buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Stock Titan
foreignpolicyjournal.com
Direct company coverage
Novo Nordisk (NYSE: NVO) Repurchases 1.24 Million B Shares as DKK 15 Billion Buyback Advances
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 18 May 2026 07:00
- Source
- foreignpolicyjournal.com
TradingView
Direct company coverage
Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- TradingView
Seeking Alpha
Direct company coverage
Novo Nordisk: A Generational Buying Opportunity Ahead Of Q1 Earnings (Preview) (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Seeking Alpha
TradingView
Direct company coverage
Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- TradingView
foreignpolicyjournal.com
Direct company coverage
Morningstar Rates Novo Nordisk (NVO) Stock Heavily Overvalued at 85 Percent Premium as Wegovy Competition Intensifies
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 01 May 2026 07:00
- Source
- foreignpolicyjournal.com
Market source
Direct company coverage
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How Novo Nordisk (NVO) Is Expanding Its Dominance in Obesity Care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Bernstein Initiates Coverage of Novo Nordisk (NVO) With an Underperform Rating
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Reuters
Direct company coverage
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Reuters